2019
DOI: 10.22330/he/34/010-016
|View full text |Cite
|
Sign up to set email alerts
|

Manipulation Checking the Munchies: Validating Self-Reported Dietary Behaviors during Cannabis Intoxication

Abstract: The prevalence and rate of cannabis use will likely increase as the relevant legal framework becomes more permissive across many municipalities. All policies and practices should be informed by scientific evidence and the public health framework for cannabis users may benefit from research and interventions promoting harm reduction. Naturalistic observations are particularly valuable for understanding patterns of human behavior and can complement and validate information collected through other methods, such a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 17 publications
0
7
0
Order By: Relevance
“…Furthermore, a very low dose (0.001 mg/kg) of ∆ 8 -THC, which is supposedly a more stable and potent CB 1 R agonist than ∆ 9 -THC, stimulated food intake but did not promote weight gain in mice 39 . Notwithstanding, our observed null effect of oral THC on daily caloric intake goes against the acclaimed hyperphagic effects of cannabis or THC 13,35,40 . Our findings, instead, reinforce the conclusion that depending on its interaction with CB 1 R on GABAergic or glutamatergic neurons, THC can produce opposite effects on appetite 41 .…”
Section: Discussionmentioning
confidence: 45%
See 1 more Smart Citation
“…Furthermore, a very low dose (0.001 mg/kg) of ∆ 8 -THC, which is supposedly a more stable and potent CB 1 R agonist than ∆ 9 -THC, stimulated food intake but did not promote weight gain in mice 39 . Notwithstanding, our observed null effect of oral THC on daily caloric intake goes against the acclaimed hyperphagic effects of cannabis or THC 13,35,40 . Our findings, instead, reinforce the conclusion that depending on its interaction with CB 1 R on GABAergic or glutamatergic neurons, THC can produce opposite effects on appetite 41 .…”
Section: Discussionmentioning
confidence: 45%
“…Notably, alcohol or cannabis use during adolescence can alter the ontogeny of neural systems that regulate cognitive and reward-related behaviors 8,9 to provoke aberrant brain functioning later in life 10,11 . Similar neural alterations can translate into an increased motivation to consume palatable, energy-dense diets during young adulthood 12,13 . Despite the popularity of alcohol and cannabis co-use 14 , there is paucity of studies on how such co-use affects energy balance and metabolic outcomes during abstinence.…”
Section: Introductionmentioning
confidence: 97%
“…Our results found no relationship between cannabis use and eating disorder or depression symptoms. These results are surprising given the link between the endocannabinoid system, appetite cues, and mood (Capodice & Kaplan, 2021; D’Addario et al, 2014) as well as the literature among non-BE samples linking cannabis use with overeating (Fouladi et al, 2015; Kirkham, 2005; Kruger et al, 2019; Soria-Gómez et al, 2014; Vidot et al, 2016) and depression (Langlois et al, 2021). Of note, symptom variability may have been limited in our sample.…”
Section: Discussionmentioning
confidence: 91%
“…This stimulation results in increased sensitivity to the hedonic properties of food (D’Addario et al, 2014; Gatta-Cherifi & Cota, 2016) and a preference for highly palatable foods (e.g., high sugar/fat foods; DiPatrizio et al, 2013). Observed increases in appetite and disinhibited eating following cannabis use in nonclinical samples (Kirkham, 2005; Kruger et al, 2019; Soria-Gómez et al, 2014) could increase risk for BE in clinical samples. Although the acute effects of cannabis promote disinhibited eating, individuals who use cannabis have been found to report greater weight and shape concerns and restrictive eating compared to individuals who do not use cannabis among a sample of postbariatric surgery patients (Vidot et al, 2016).…”
mentioning
confidence: 99%
“…The potential role for the ECS in depression comes from a series of studies indicating that the CB1r antagonist rimonabant is associated with the development of severe adverse effects, including depression and suicide [ 151 ]. Clinical observations showed that cannabis stimulates appetite (the “munchies”) [ 152 ]. Rimonabant was developed as an anti-obesity treatment.…”
Section: The Ecs In Human Studies Of Depressionmentioning
confidence: 99%